Nyumbani › Limfoma › Washington › Seattle
Majaribio ya kliniki ya Limfoma katika Seattle, WA
Masomo 12 ya Limfoma yanatafuta washiriki katika vituo vya Seattle na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
InaajiriHatua 2
- Fred Hutchinson Cancer Center, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
InaajiriHatua 2
- Fred Hutchinson Cancer Center, Seattle
Collection of Tissue Samples for Cancer Research
InaajiriUtafiti wa uchunguzi
- Fred Hutchinson, Seattle
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
- Seattle Children s Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
InaajiriHatua 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
InaajiriHatua 1
- Fred Hutch Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
InaajiriHatua 2
- Fred Hutchinson Cancer Center, Seattle
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
InaajiriHatua 1/2
- Dren Investigational Site, Seattle
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
InaajiriUtafiti wa uchunguzi
- Seattle Children's Hospital, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
InaajiriHatua 1/2
- University of Washington Medical Center, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
InaajiriHatua 2
- Fred Hutchinson Cancer Center, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
InaajiriHatua 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Majaribio ya Limfoma katika miji mingine
- Houston, TXUtafiti 34
- Boston, MAUtafiti 33
- New York City, NYUtafiti 33
- Washington, DCUtafiti 23
- Baldwin Park, CAUtafiti 21
- Chicago, ILUtafiti 20
- Durham, NCUtafiti 17
- St. Louis, MOUtafiti 15
- Philadelphia, PAUtafiti 15
- Cleveland, OHUtafiti 14
- Edison, NJUtafiti 12
- Atlanta, GAUtafiti 12
Masomo mengine katika Seattle
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 53
- Saratani (aina zote)Utafiti 49
- Saratani ya ProstateUtafiti 42
- Leukemia ya Myeloid ya GhaflaUtafiti 40
- Saratani ya MatitiUtafiti 39
- Saratani ya MetastasiUtafiti 39
- Kansari ya kolorektaliUtafiti 34
- Saratan ya MapafuUtafiti 33
- Kansari ya MayaiUtafiti 30
- Multiple MyelomaUtafiti 22
- Sindromu za MyelodysplasticUtafiti 21
- Leukemia ya Lymphoblastic ya GhaflaUtafiti 21
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.